US 7244735
Heterocyclic protein kinase inhibitors and uses thereof
granted A61KA61K31/506A61K45/06
Quick answer
US patent 7244735 (Heterocyclic protein kinase inhibitors and uses thereof) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K31/506, A61K45/06, A61P, A61P1/04